United States Biotechnology & Medical Research

ARIAD Pharmaceuticals Inc (ARIA)

Track

Ticker: ARIA Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 9 Jan 2017
Value US$3,338,806.96 | Price 312.66 | Shares 59,861 (-5.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-01-10 2017-01-09 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality
59,861 -5.4%
312.66
US$3,338,807 		59,861 -5.4% 312.66 US$3,338,807
2016-10-25 2016-10-24 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
16,122 +8.0%
364.88
US$3,222,163 		16,122 +8.0% 364.88 US$3,222,163
2016-10-05 2016-10-03 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
82,427 -43.3%
450.82
US$3,171,823 		82,427 -43.3% 450.82 US$3,171,823
2016-09-28 2016-09-28 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
8,750 -3.9%
13.98
US$122,311 		8,750 -3.9% 13.98 US$122,311
2016-09-23 2016-09-22 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
20,000 -8.7%
13.43
US$268,536 		20,000 -8.7% 13.43 US$268,536
2016-09-16 2016-09-15 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
59,369 -20.6%
11.73
US$696,398 		59,369 -20.6% 11.73 US$696,398
2016-08-23 2016-08-22 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
19,436 -7.8%
10.47
US$203,538 		19,436 -7.8% 10.47 US$203,538
2016-08-15 2016-08-12 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
25,000 -9.2%
10.50
US$262,500 		25,000 -9.2% 10.50 US$262,500
2016-07-25 2016-07-22 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
18,286 -6.9%
8.11
US$148,230 		18,286 -6.9% 8.11 US$148,230
2016-07-05 2016-07-01 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
30,000 -10.1%
7.48
US$224,481 		30,000 -10.1% 7.48 US$224,481
2016-07-05 2016-07-01 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
31,422 -10.5%
7.48
US$235,153 		31,422 -10.5% 7.48 US$235,153
2016-06-29 2016-06-28 S Sale Cole Hugh M

SVP, Chief Business Officer

Officer
6,012 -16.7%
7.05
US$42,385 		6,012 -16.7% 7.05 US$42,385
2016-06-23 2016-06-22 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
23,999 -8.3%
7.28
US$174,638 		23,999 -8.3% 7.28 US$174,638
2016-06-15 2016-06-15 S Sale LAVIDAS ATHANESE Non-Executive Director
46,250 -26.0%
8.24
US$381,137 		46,250 -26.0% 8.24 US$381,137
2016-06-15 2016-06-14 S Sale LAVIDAS ATHANESE Non-Executive Director
20,000 -13.2%
8.14
US$162,852 		20,000 -13.2% 8.14 US$162,852
2016-06-14 2016-06-14 S Sale Radaelli Massimo Non-Executive Director
6,250 -5.6%
8.13
US$50,834 		6,250 -5.6% 8.13 US$50,834
2016-06-15 2016-06-13 S Sale LAVIDAS ATHANESE Non-Executive Director
10,000 -7.1%
8.21
US$82,050 		10,000 -7.1% 8.21 US$82,050
2016-06-14 2016-06-13 S Sale Radaelli Massimo Non-Executive Director
79,731 -43.0%
8.25
US$657,821 		79,731 -43.0% 8.25 US$657,821
2016-06-14 2016-06-10 S Sale Radaelli Massimo Non-Executive Director
22,588 -17.6%
8.30
US$187,480 		22,588 -17.6% 8.30 US$187,480
2016-05-25 2016-05-23 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
17,762 -5.8%
8.08
US$143,430 		17,762 -5.8% 8.08 US$143,430
2016-05-13 2016-05-12 B Purchase Panayiotopoulos Paris

President and CEO

Executive Director
26,990 +44.2%
7.41
US$199,996 		26,990 +44.2% 7.41 US$199,996
2016-05-02 2016-05-02 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
11,700 -3.7%
7.13
US$83,478 		11,700 -3.7% 7.13 US$83,478
2016-04-25 2016-04-22 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
21,409 -6.8%
7.37
US$157,864 		21,409 -6.8% 7.37 US$157,864
2016-03-23 2016-03-22 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
23,834 -7.0%
6.58
US$156,871 		23,834 -7.0% 6.58 US$156,871
2016-03-22 2016-03-21 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
3,575 -2.4%
6.47
US$23,116 		3,575 -2.4% 6.47 US$23,116
2016-03-22 2016-03-21 PlS Planned sale FITZGERALD EDWARD M

Executive VP

Officer
5,417 -1.7%
6.47
US$35,037 		5,417 -1.7% 6.47 US$35,037
2016-03-22 2016-03-21 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
2,375 -0.9%
6.47
US$15,356 		2,375 -0.9% 6.47 US$15,356
2016-03-22 2016-03-21 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
4,000 -2.5%
6.47
US$25,871 		4,000 -2.5% 6.47 US$25,871
2016-03-22 2016-03-19 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
4,000 -4.1%
6.47
US$25,867 		4,000 -4.1% 6.47 US$25,867
2016-03-22 2016-03-19 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
5,417 -1.6%
6.47
US$35,039 		5,417 -1.6% 6.47 US$35,039
2016-03-22 2016-03-19 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
3,575 -2.6%
6.46
US$23,102 		3,575 -2.6% 6.46 US$23,102
2016-03-03 2016-03-03 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
9,625 -9.8%
6.12
US$58,863 		9,625 -9.8% 6.12 US$58,863
2016-03-03 2016-03-03 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
9,625 -6.0%
6.11
US$58,852 		9,625 -6.0% 6.11 US$58,852
2016-03-03 2016-03-03 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
9,625 -6.8%
6.12
US$58,869 		9,625 -6.8% 6.12 US$58,869
2016-03-03 2016-03-03 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
9,625 -2.8%
6.12
US$58,867 		9,625 -2.8% 6.12 US$58,867
2016-03-03 2016-03-03 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
9,625 -3.0%
6.12
US$58,866 		9,625 -3.0% 6.12 US$58,866
2016-03-03 2016-03-03 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
10,588 -6.8%
6.11
US$64,733 		10,588 -6.8% 6.11 US$64,733
2016-03-03 2016-03-03 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
9,625 -3.6%
6.12
US$58,887 		9,625 -3.6% 6.12 US$58,887
2016-03-03 2016-03-02 S Sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
25,047 -6.8%
6.00
US$150,282 		25,047 -6.8% 6.00 US$150,282
2016-02-03 2016-02-01 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
16,133 -10.6%
4.81
US$77,587 		16,133 -10.6% 4.81 US$77,587
2016-02-03 2016-02-01 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
14,667 -10.6%
4.81
US$70,517 		14,667 -10.6% 4.81 US$70,517
2016-02-03 2016-02-01 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
1,466 -1.1%
4.93
US$7,227 		1,466 -1.1% 4.93 US$7,227
2016-02-03 2016-02-01 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
14,667 -15.6%
4.81
US$70,578 		14,667 -15.6% 4.81 US$70,578
2016-02-03 2016-02-01 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
14,667 -4.0%
4.81
US$70,517 		14,667 -4.0% 4.81 US$70,517
2016-02-03 2016-02-01 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
14,667 -9.4%
4.81
US$70,548 		14,667 -9.4% 4.81 US$70,548
2016-02-03 2016-02-01 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
14,667 -5.5%
4.81
US$70,515 		14,667 -5.5% 4.81 US$70,515
2016-02-03 2016-02-01 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
14,667 -4.6%
4.81
US$70,515 		14,667 -4.6% 4.81 US$70,515
2016-02-03 2016-02-01 B Purchase Panayiotopoulos Paris

President and CEO

Executive Director
61,099 +inf%
4.91
US$299,996 		61,099 +inf% 4.91 US$299,996
2015-09-28 2015-09-28 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
5,000 -4.4%
6.47
US$32,326 		5,000 -4.4% 6.47 US$32,326
2015-09-28 2015-09-28 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
8,750 -2.9%
6.46
US$56,551 		8,750 -2.9% 6.46 US$56,551
2015-09-28 2015-09-28 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
5,000 -2.0%
6.46
US$32,316 		5,000 -2.0% 6.46 US$32,316
2015-09-28 2015-09-28 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
5,000 -7.2%
6.46
US$32,316 		5,000 -7.2% 6.46 US$32,316
2015-09-28 2015-09-28 S Sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
5,000 -3.8%
6.46
US$32,316 		5,000 -3.8% 6.46 US$32,316
2015-09-28 2015-09-28 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
5,500 -4.3%
6.46
US$35,502 		5,500 -4.3% 6.46 US$35,502
2015-09-28 2015-09-28 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
8,750 -2.6%
6.46
US$56,560 		8,750 -2.6% 6.46 US$56,560
2015-07-16 2015-07-16 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
4,400 -3.6%
8.54
US$37,575 		4,400 -3.6% 8.54 US$37,575
2015-07-16 2015-07-16 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
1,400 -2.3%
8.54
US$11,956 		1,400 -2.3% 8.54 US$11,956
2015-07-16 2015-07-16 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
7,000 -2.2%
8.54
US$59,793 		7,000 -2.2% 8.54 US$59,793
2015-07-16 2015-07-16 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
7,000 -2.1%
8.54
US$59,797 		7,000 -2.1% 8.54 US$59,797
2015-07-16 2015-07-16 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
4,000 -3.5%
8.54
US$34,162 		4,000 -3.5% 8.54 US$34,162
2015-07-16 2015-07-16 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
4,000 -1.7%
8.54
US$34,162 		4,000 -1.7% 8.54 US$34,162
2015-07-16 2015-07-16 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
4,000 -3.2%
8.54
US$34,164 		4,000 -3.2% 8.54 US$34,164
2015-05-04 2015-05-01 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
60,000 -16.4%
8.80
US$528,000 		60,000 -16.4% 8.80 US$528,000
2015-03-23 2015-03-23 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
2,000 -1.2%
8.56
US$17,118 		2,000 -1.2% 8.56 US$17,118
2015-03-23 2015-03-23 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
3,000 -2.5%
8.55
US$25,660 		3,000 -2.5% 8.55 US$25,660
2015-03-23 2015-03-23 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
4,167 -1.3%
8.55
US$35,630 		4,167 -1.3% 8.55 US$35,630
2015-03-23 2015-03-23 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
834 -1.5%
8.57
US$7,145 		834 -1.5% 8.57 US$7,145
2015-03-23 2015-03-23 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
3,300 -2.8%
8.55
US$28,229 		3,300 -2.8% 8.55 US$28,229
2015-03-23 2015-03-23 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs and HR

Officer
4,033 -3.7%
8.55
US$34,491 		4,033 -3.7% 8.55 US$34,491
2015-03-23 2015-03-23 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
6,667 -1.5%
8.55
US$57,016 		6,667 -1.5% 8.55 US$57,016
2015-03-23 2015-03-20 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
2,375 -1.5%
8.85
US$21,026 		2,375 -1.5% 8.85 US$21,026
2015-03-23 2015-03-20 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
4,000 -3.4%
8.85
US$35,390 		4,000 -3.4% 8.85 US$35,390
2015-03-23 2015-03-20 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
5,417 -1.8%
8.84
US$47,908 		5,417 -1.8% 8.84 US$47,908
2015-03-23 2015-03-20 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
4,000 -6.9%
8.85
US$35,381 		4,000 -6.9% 8.85 US$35,381
2015-03-23 2015-03-20 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
3,575 -3.1%
8.85
US$31,634 		3,575 -3.1% 8.85 US$31,634
Explore more

More insider trading research around ARIAD Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America